1. Home
  2. OSBC vs PHAR Comparison

OSBC vs PHAR Comparison

Compare OSBC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Second Bancorp Inc.

OSBC

Old Second Bancorp Inc.

HOLD

Current Price

$23.15

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.77

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSBC
PHAR
Founded
1981
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
885.7M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
OSBC
PHAR
Price
$23.15
$13.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$23.50
$38.33
AVG Volume (30 Days)
358.5K
4.8K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.36%
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
N/A
N/A
Revenue This Year
$25.20
$10.04
Revenue Next Year
$3.66
$2.51
P/E Ratio
$48.40
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$16.43
$9.54
52 Week High
$23.95
$21.34

Technical Indicators

Market Signals
Indicator
OSBC
PHAR
Relative Strength Index (RSI) 63.75 57.84
Support Level $19.21 $12.98
Resistance Level N/A $17.60
Average True Range (ATR) 0.56 0.38
MACD 0.09 0.19
Stochastic Oscillator 70.61 86.30

Price Performance

Historical Comparison
OSBC
PHAR

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: